Financial Data and Key Metrics Changes - For Q1 2025, the company reported GAAP net income of approximately 9.3millionor0.17 per common share, with distributable earnings of approximately 7.2millionor0.13 per common share [10] - The company collected 3,700,000inrepaymentsacrossnineloans,doubletheamountfromthepreviousquarter,markingthehighestrepaymentsasapercentageofoutstandingprincipalbalanceinthecompany′shistory[5][11]−Outstandingborrowingswerereducedby228 million to 946million,resultinginanetdebttoequityratioof1.2times,downfrom1.9timesattheendofQ12024[5][11]BusinessLineDataandKeyMetricsChanges−Thecompanyreduceditsofficeloanportfolioby25585 million [6] - There were no new migrations to risk-rated four or five loans in Q1 2025, indicating improved credit quality across the portfolio [10][11] Market Data and Key Metrics Changes - The total CECL reserve declined to 140millionasofQ12025,adecreaseofapproximately5 million from the previous quarter, representing about 9.9% of the total outstanding principal balance of loans held for investment [14] Company Strategy and Development Direction - The company aims to demonstrate book value and is positioned to selectively originate new loans, repurchase common shares, repay debt, and fund strategic initiatives [8][9] - The acquisition of GCP has expanded the company's real estate team, enhancing its ability to execute its strategy and deliver shareholder returns [18][45] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the uncertainty in the economic environment but expressed confidence in the company's capabilities and balance sheet strength to build shareholder value [18][19] - The company is being selective in new lending opportunities, waiting for market stabilization before expanding its loan portfolio [32][34] Other Important Information - The Board declared a regular cash dividend of 0.15percommonshareforQ22025,withanannualizeddividendyieldofover1450 million buyback authorization in place and is evaluating the use of additional capital for stock repurchases [37] Question: Update on the Life Science Boston project - Management acknowledged challenges in the market but indicated ongoing discussions with the sponsor and a cautious approach to reserves [40][41] Question: Clarification on strategic initiatives - Management clarified that strategic initiatives include evaluating share buybacks and new investments, particularly in light of the GCP acquisition [42][45]